Jaseong Koo

Dr. Jaseong Koo

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
JKJean Hee Kim
Jean Hee Kim
JKJaseong Koo
Jaseong Koo
KLKijeong Lee
Kijeong Lee

2 May 2022 in World Neurosurgery
Verified
Journal Article
Closed access
JJJinhee Jang
Jinhee Jang
JLJung Koo Lee
Jung Koo Lee
JKJaseong Koo
Jaseong Koo
BKBum-Soo Kim
Bum-Soo Kim
YSYong Sam Shin
Yong Sam Shin
JCJai Ho Choi
Jai Ho Choi

1 January 2021 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
KHKeun-Sik Hong
Keun-Sik Hong
SKSun Uck Kwon
Sun Uck Kwon
JCJae-Kwan Cha
Jae-Kwan Cha
JJJin-Man Jung
Jin-Man Jung
YKYong-Jae Kim
Yong-Jae Kim
MOMi Sun Oh
Mi Sun Oh
Hong KS, et al. J Clin Neurol. 2021 Jul;17(3):344-353. https://doi.org/10.3988/jcn.2021.17.3.344

12 August 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
HLHan-Bin Lee
Han-Bin Lee
SOSang Hoon Oh
Sang Hoon Oh
JJJinhee Jang
Jinhee Jang
JKJaseong Koo
Jaseong Koo
HBHyo Jin BANG
Hyo Jin BANG
MLMin Hwan Lee
Min Hwan Lee
The optic nerve sheath diameter (ONSD) can predict intracranial pressure and outcomes in neurological disease, but it remains unclear whether a small ONSD can be accurately measured on routine CT images with a slice thickness of approximately 4–5 mm. We measured the ONSD and ONSD/eyeball transverse diameter (ETD) ratio on routine-slice (4 mm) and thin-slice (0.6–0.75 mm) brain CT images from initial scans of acute ischemic stroke (AIS) patients. ONSD-related variables, National Institutes of Health Stroke Scale (NIHSS) scores, and age were compared between good (modified Rankin Scale [mRS] ≤ 2) and poor (mRS > 2) outcomes at discharge. Among 155 patients, 38 had poor outcomes. The thin-slice ONSD was different between outcome groups (p = 0.047), while the routine-slice ONSD showed no difference. The area under the curve (AUC) values for the ONSD and ONSD/ETD were 0.58 (95% CI, 0.49–0.66) and 0.58 (95% CI, 0.50–0.66) on the routine-slice CT, and 0.60 (95% CI, 0.52–0.68) and 0.62 (95% CI, 0.54–0.69) on the thin-slice CT. The thin-slice ONSD/ETD ratio correlated with initial NIHSS scores (r = 0.225, p = 0.005). After adjusting for NIHSS scores and age, ONSD-related variables were not associated with outcomes, and adding them to a model with NIHSS scores and age did not improve performance (all p-values > 0.05). Although ONSD measurements were not an independent outcome predictor, they correlated with stroke severity, and the thin-slice ONSD provided a slightly better prognostic performance than the routine-slice ONSD.

31 December 2025 in Journal of Neurosonology and Neuroimaging
Verified
Journal Article
Open access
PDF file
JYJi Hye Yang
Ji Hye Yang
SPSung Jin Park
Sung Jin Park
MLMin Hwan Lee
Min Hwan Lee
HLHan-Bin Lee
Han-Bin Lee
JKJaseong Koo
Jaseong Koo
A-Hyun ChoA-Hyun Cho
A-Hyun Cho
Background: Poor outcomes after acute ischemic stroke (AIS) revascularization are anticipated in patients with dementia due to advanced age, comorbidities, and reduced disease awareness. This study investigated clinical characteristics and short-term outcomes of AIS revascularization in patients undergoing dementia treatment.Methods: We retrospectively reviewed patients who underwent AIS revascularization therapy at eight centers of the Catholic University of Korea. Patients receiving anti-dementia medication for cognitive impairment before stroke onset were analyzed. Clinical characteristics and outcomes, including the modified Rankin Scale (mRS) score, hemorrhagic transformation, and mortality, were collected.Results: Among 1,379 patients who received AIS revascularization over 5 years, 13 (0.94%; mean age 83 years; 8 females) had a preexisting diagnosis of dementia (Alzheimer’s disease in 11, mild cognitive impairment in 2) and were on anti-dementia medication. Two patients underwent intravenous thrombolysis combined with endovascular therapy, whereas 11 underwent endovascular therapy alone. Most patients (11/13, 84.6%) presented with an unclear onset time. Stroke lesions were located in the right middle cerebral artery (MCA) in seven cases, left MCA in three, bilateral MCAs in one, and posterior circulation in two. Hemorrhagic transformation occurred in six patients (46%), of whom three (23%) were symptomatic. The mRS scores at discharge were 6 in two patients, 5 in one patient, 4 in nine patients, and 3 in one patient. Four patients died within 3 months of stroke onset.Conclusion: The proportion of patients with cognitive impairment receiving anti-dementia medication among those undergoing stroke revascularization therapy was very small. The rates of hemorrhagic transformation and mortality were high. None of the patients achieved favorable outcomes at discharge.

31 December 2019 in Journal of Neurosonology and Neuroimaging
Verified
Journal Article
Open access
PDF file
KJKipyoung Jeon
Kipyoung Jeon
CLChonghwee Lee
Chonghwee Lee
KLKijeong Lee
Kijeong Lee
HCHyun Seok Choi
Hyun Seok Choi
BKBum-soo Kim
Bum-soo Kim
JKJaseong Koo
Jaseong Koo